Clinical Trial Update: Comparison of Oral Versus Subcutaneous Route of Methotrexate Administration in Moderate to Severe Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing oral versus subcutaneous methotrexate for psoriasis; current status is not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Psoriasis Vulgaris | Phase 4 | Status: UNKNOWN